Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Non-Current Deffered Revenue (2017 - 2025)

Neuronetics (STIM) has disclosed Non-Current Deffered Revenue for 8 consecutive years, with $2000.0 as the latest value for Q4 2024.

  • On a quarterly basis, Non-Current Deffered Revenue fell 99.0% to $2000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $2000.0, a 99.0% decrease, with the full-year FY2024 number at $2000.0, down 99.0% from a year prior.
  • Non-Current Deffered Revenue was $2000.0 for Q4 2024 at Neuronetics, down from $4000.0 in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $2.0 million in Q1 2020 to a low of $2000.0 in Q4 2024.
  • A 5-year average of $975800.0 and a median of $1.1 million in 2022 define the central range for Non-Current Deffered Revenue.
  • Peak YoY movement for Non-Current Deffered Revenue: increased 7.3% in 2020, then plummeted 99.0% in 2024.
  • Neuronetics' Non-Current Deffered Revenue stood at $1.7 million in 2020, then dropped by 15.51% to $1.5 million in 2021, then crashed by 43.64% to $829000.0 in 2022, then plummeted by 75.87% to $200000.0 in 2023, then tumbled by 99.0% to $2000.0 in 2024.
  • Per Business Quant, the three most recent readings for STIM's Non-Current Deffered Revenue are $2000.0 (Q4 2024), $4000.0 (Q3 2024), and $15000.0 (Q2 2024).